Marex Group plc - Ordinary Shares (MRX) Covered Calls
Medicis Pharmaceutical Corporation focuses on helping patients attain a healthy and youthful appearance and self-image through the development and marketing in the U.S. of products for the treatment of dermatological and aesthetic conditions.
You can sell covered calls on Marex Group plc - Ordinary Shares to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for MRX (prices last updated Fri 4:16 PM ET):
| Marex Group plc - Ordinary Shares (MRX) Stock Quote | ||||||
|---|---|---|---|---|---|---|
| Last | Change | Bid | Ask | Volume | P/E | Market Cap |
| 28.34 | -0.63 | 27.53 | 29.29 | 546K | - | 2.1 |
| Covered Calls For Marex Group plc - Ordinary Shares (MRX) | ||||||
|---|---|---|---|---|---|---|
| Expiration | Strike | Call Bid | Net Debit | Return If Flat |
Annualized Return If Flat |
|
| Dec 20 | 30 | 0.80 | 28.49 | 3.3% | 33.5% | |
| Jan 17 | 30 | 0.00 | 29.29 | 0.5% | 2.9% | |
| Subscribers get access to the full covered call chain, and more features. | ||||||
Want to make money with covered calls? Sign Up For A Free Trial
Extended Business Description
Medicis Pharmaceutical Corp. provides pharmaceutical products for the treatment of dermatological, aesthetic and podiatric conditions. It offers a broad range of products addressing various conditions or aesthetic improvements, including facial wrinkles, glabellar lines, acne, fungal infections, rosacea, hyperpigmentation, photoaging, psoriasis, seborrheic dermatitis and cosmesis. It operates through The Dermatological and Non-Dermatological businesses. The Dermatological business represents products for the treatment of acne and acne-related dermatological conditions and non-acne dermatological conditions. The non-dermatological field represents products for the treatment of urea cycle disorder, noninvasive body sculpting technology and contract revenue. The Non-Dermatological product lines include AMMONUL, BUPHENYL and the LIPOSONIXTM system. It was founded by Jonah Shacknai and John W. Holaday on July 28, 1988 and is headquartered in Scottsdale, AZ.
| Top 10 Open Interest For Dec 20 Expiration | Top 5 High Yield | |||||
|---|---|---|---|---|---|---|
| 1. | NVDA covered calls | 6. | QQQ covered calls | 1. | SAVA covered calls | |
| 2. | SPY covered calls | 7. | XLF covered calls | 2. | RKLB covered calls | |
| 3. | EEM covered calls | 8. | KWEB covered calls | 3. | LUNR covered calls | |
| 4. | FXI covered calls | 9. | TLT covered calls | 4. | NMRA covered calls | |
| 5. | IWM covered calls | 10. | KRE covered calls | 5. | CRVS covered calls | |
Want more examples? MRVL Covered Calls | MS Covered Calls
